Yatsen CSO reports option and share holdings
Yatsen Holding Ltd Chief Scientific Officer Cheng Jing filed an initial statement of holdings.
Rhea-AI Filing Summary
Yatsen Holding Ltd Chief Scientific Officer Cheng Jing filed an initial statement of holdings. The filing reports share options covering 11,824,609 Class A ordinary shares at an exercise price of $0.0250 per share, expiring on February 28, 2033. These options were granted on February 28, 2023 and vest over five years, with specific tranches vesting annually from February 1, 2024 through February 1, 2028 under an award agreement. In addition, 76,000 Class A ordinary shares are reported as held indirectly through the officer’s spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Options (Right to Buy) | -- | -- | -- |
| holding | Class A ordinary shares | -- | -- | -- |
Footnotes (1)
- F1. Represents share options granted on February 28, 2023. The options vest over a 5-year period, with 1,035,900 shares vesting on February 1, 2024, 2,697,160 shares vesting on February 1, 2025, 2,697,160 shares vesting on February 1, 2026, 2,697,160 shares vesting on February 1, 2027, and 2,697,229 shares vesting on February 1, 2028, subject to the terms and conditions of the underlying award agreement.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Yatsen Holding (YSG) Chief Scientific Officer report on this Form 3?
Does this Yatsen (YSG) Form 3 show any recent insider buying or selling?
AI-generated analysis. How Rhea-AI works. Not financial advice.